Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Long-Term Investments (2022 - 2025)

Historic Long-Term Investments for Cellebrite DI (CLBT) over the last 4 years, with Q3 2025 value amounting to $117.1 million.

  • Cellebrite DI's Long-Term Investments rose 2866.04% to $117.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $117.1 million, marking a year-over-year increase of 2866.04%. This contributed to the annual value of $101.8 million for FY2024, which is 25281.19% up from last year.
  • Latest data reveals that Cellebrite DI reported Long-Term Investments of $117.1 million as of Q3 2025, which was up 2866.04% from $146.9 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Long-Term Investments registered a high of $146.9 million during Q2 2025, and its lowest value of $22.1 million during Q4 2022.
  • For the 4-year period, Cellebrite DI's Long-Term Investments averaged around $69.5 million, with its median value being $57.6 million (2023).
  • In the last 5 years, Cellebrite DI's Long-Term Investments surged by 669.45% in 2023 and then skyrocketed by 25281.19% in 2024.
  • Cellebrite DI's Long-Term Investments (Quarter) stood at $22.1 million in 2022, then surged by 30.44% to $28.9 million in 2023, then surged by 252.81% to $101.8 million in 2024, then increased by 15.04% to $117.1 million in 2025.
  • Its last three reported values are $117.1 million in Q3 2025, $146.9 million for Q2 2025, and $141.3 million during Q1 2025.